Efficacy and Safety of PARP Inhibitors in Advanced or Metastatic Triple-Negative Breast Cancer: A Systematic Review and Meta-Analysis

PURPOSE: Poly (ADP-ribose) polymerase (PARP) inhibitors have shown promising results in metastatic triple-negative breast cancers (TNBCs). We therefore performed a systematic review and meta-analysis to evaluate the efficacy and safety of this drug in patients with advanced or metastatic TNBC. METHO...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Xu, Wu, Kan, Zheng, Dan, Luo, Chuanxu, Fan, Yu, Zhong, Xiaorong, Zheng, Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581463/
https://www.ncbi.nlm.nih.gov/pubmed/34778059
http://dx.doi.org/10.3389/fonc.2021.742139

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581463/
https://www.ncbi.nlm.nih.gov/pubmed/34778059
http://dx.doi.org/10.3389/fonc.2021.742139

Ejemplares similares